Evidence map›Paper›PMID 42525010›Full record

ArticleCadernos de saude publica2026

Projections for lung cancer mortality in Brazil by 2045: a regional analysis.

Rejane de Souza Reis, Fernanda Cristina da Silva de Lima, Darlan Henrique Nascimento da Silva, Alfredo José Monteiro Scaff, André Salem Szklo

Abstract read
In one paragraph

Article in Cadernos de saude publica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rejane de Souza ReisFundação do Câncer, Rio de Janeiro, Brasil.ORCID http://orcid.org/0000-0003-3067-0526
Fernanda Cristina da Silva de LimaFundação do Câncer, Rio de Janeiro, Brasil.ORCID http://orcid.org/0000-0002-7815-4304
Darlan Henrique Nascimento da SilvaFundação do Câncer, Rio de Janeiro, Brasil.ORCID http://orcid.org/0009-0003-4726-3510
Alfredo José Monteiro ScaffFundação do Câncer, Rio de Janeiro, Brasil.ORCID http://orcid.org/0000-0003-3293-1689
André Salem SzkloInstituto Nacional de Câncer, Rio de Janeiro, Brasil.ORCID http://orcid.org/0000-0003-1903-6188

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective was to estimate temporal trends for lung cancer mortality in Brazil and its regions, stratified by sex and age group, from 2021 to 2045. This mortality projection study was based on lung cancer deaths (ICD-10: C33-C34) registered in the Brazilian Mortality Information System between 2001 and 2020, with redistribution of ill-defined causes. Crude and age-adjusted rates were calculated according to the 1960 world standard population. The projections adopted the Nordpred model in the R program, in 5-year periods from 2021 to 2045. There was a projected increase in the absolute number of deaths in both sexes, especially in the South and Southeast regions. The age-adjusted rates indicate a downward trend among men in all regions, despite remaining higher in the South. Among women, there was growth by 2025, followed by stability or a slight reduction by 2045, with the highest rates in the South Region. Population aging contributes to the increase in crude rates, even with the decline in adjusted rates. The projections suggest persistent regional inequalities, which may be associated with historical smoking patterns and unequal access to lung cancer diagnosis and treatment. The findings reinforce the need for regional prevention and control policies, including addressing smoking and considering the new forms of nicotine consumption, such as electronic cigarettes.

Indexed as

Lung NeoplasmsAdultAgedAge DistributionBrazilFemaleForecastingHumansMaleMiddle AgedSex DistributionYoung Adult

Identifiers

PMID42525010
PMCPMC13411256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.